Exact Mass: 361.2172292
Exact Mass Matches: 361.2172292
Found 47 metabolites which its exact mass value is equals to given mass value 361.2172292
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
4-Hydroxydecanedioylcarnitine
C17H31NO7 (361.21004159999995)
4-Hydroxydecanedioylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxydecanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Hydroxydecanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Hydroxydecanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
3-Hydroxydecanedioylcarnitine
C17H31NO7 (361.21004159999995)
3-Hydroxydecanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxydecanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Hydroxydecanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Hydroxydecanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
5-Hydroxydecanedioylcarnitine
C17H31NO7 (361.21004159999995)
5-Hydroxydecanedioylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxydecanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Hydroxydecanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Hydroxydecanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentan-1-yl)-1H-indole-3-carboxamide
20-ethyl-1alpha,8-dihydroxy-4-methyl-heteratisan-14-one|Hetereophyllin|heterophylline|heterophylline (Aconitum)
C21H31NO4 (361.22529660000004)
methyl (2R,5S,8S,15R)-5-ethyl-6-hydroxy-2-hydroxymethyl-6-azapentacyclo[9.5.1.01,5.02,8.014,17]heptadec-11(17)-ene-15-carboxylate|N-hydroxypaxdaphnine B
C21H31NO4 (361.22529660000004)
Liconosine A|N-deethyl-N,19-didehydrosachaconitine|N-deethyl-N-19-didehydrosachaconitine
C21H31NO4 (361.22529660000004)
anti-testosterone-3-CMO
C21H31NO4 (361.22529660000004)
6-(4-(Ethoxycarbonyl)piperazin-1-yl)pyridine-3-boronic acid pinacol ester
C18H28BN3O4 (361.21727580000004)
BENZYL N-BOC-4-ISOPROPYL-4-PIPERIDINECARBOXYLATE
C21H31NO4 (361.22529660000004)
1,3-Propanediamine,N1,N1-diethyl-N3-(6-methyl-5H-pyrido[3,4:4,5]pyrrolo[2,3-g]isoquinolin-10-yl)-
butyl prop-2-enoate,N-(methoxymethyl)-2-methylprop-2-enamide,styrene
C21H31NO4 (361.22529660000004)
(2R)-2-[(4-tert-butylphenyl)methyl]-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid
C21H31NO4 (361.22529660000004)
1-TRIISOPROPYLSILANYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID METHOXY-METHYL-AMIDE
Furethidine
C21H31NO4 (361.22529660000004)
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist
BOC-(S)-ALPHA-(4-TERT-BUTYL-BENZYL)-PROLINE
C21H31NO4 (361.22529660000004)
1-Butanol, 4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]-
C23H27N3O (361.21540120000003)
N-cyclohexyl-2-(4-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)phenoxy)acetamide
C21H31NO4 (361.22529660000004)
Prenoxdiazine
C23H27N3O (361.21540120000003)
R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent
11-[2-(Diethylamino)ethylamino]-7,8,9,10-tetrahydrobenzimidazolo[1,2-b]isoquinoline-6-carbonitrile
1-[4-(2,3-Dimethylphenyl)-1-piperazinyl]-2-(1-methyl-3-indolyl)ethanone
C23H27N3O (361.21540120000003)
2-(dimethylamino)-1-[(1S,5R)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone
C23H27N3O (361.21540120000003)
(3R,11R)-11-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydodecanoate
C18H33O7- (361.22261679999997)
(3R)-12-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydodecanoate
C18H33O7- (361.22261679999997)
4-(2-Butanoyloxy-3-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
C17H31NO7 (361.21004159999995)
4-(3-Acetyloxy-2-pentanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
C17H31NO7 (361.21004159999995)
2-hydroxy-9a-methoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,8ah,9h-cyclohexa[f]indol-6-yl 2-methylbut-2-enoate
C21H31NO4 (361.22529660000004)
(4as,5r,6s,8ar,9ar)-2-hydroxy-9a-methoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,8ah,9h-cyclohexa[f]indol-6-yl (2z)-2-methylbut-2-enoate
C21H31NO4 (361.22529660000004)
(1s,4s,9s,12s,13s,16r,17r)-17-(hydroxymethyl)-9-methoxy-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol
C21H31NO4 (361.22529660000004)
(1r,2s,3s,5r,7s,10r,11s,13r,14r,17s,18s,19r)-4-ethyl-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-13,14,18-triol
C21H31NO4 (361.22529660000004)
(1s,4s,9s,12s,13r,16r,17r)-17-(hydroxymethyl)-9-methoxy-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol
C21H31NO4 (361.22529660000004)